Cefpodoxime Proxetil Dry Syrup

Beta Lactams · Dry Syrup / Oral Suspension · 50mg/5ml, 100mg/5ml

Trade Information

Minimum Order Qty	100,000 bottles
Capacity	5 Million Bottles per month
Strength	50mg/5ml, 100mg/5ml
Private Labelling	Custom branding, artwork & market-specific labelling
Lead Time	45–60 days from order confirmation
Payment Terms	LC at sight, TT (advance / against documents)
Shipping	FOB / CIF to major international ports including Mombasa, Dar es Salaam, Lagos, Durban, Manila, Phnom Penh
Pharmacopoeia	BP, USP, IP compliant

Packing Options

Dry syrup bottle (glass / PET)
Bottle with measuring cup
Hospital bulk pack
Custom packing as per buyer requirement

Regulatory & Quality

Registration Status	Registered in multiple African, Asian, and CIS markets. Dossier available for new market registration.
Regulatory Dossiers	CTD / ACTD format dossiers available for submission to national drug authorities.
Stability Data	Zone IVa & IVb stability data available (tropical climate conditions, 30°C/65% RH & 30°C/75% RH)
WHO Prequalification	WHO-GMP Certified

Product Details

Composition	Cefpodoxime Proxetil
Dosage Form	Dry Syrup / Oral Suspension
Pack Size	Bottle with measuring device (30ml / 60ml) / Custom packing available
Storage	Store below 25°C in a dry place, protected from light and moisture
Shelf Life	24 months from date of manufacture

Description

Cefpodoxime Proxetil is a third-generation oral cephalosporin offering a balanced spectrum against both Gram-positive and Gram-negative organisms, widely used in respiratory tract infections and otitis media. It is listed on the WHO Model List of Essential Medicines.

BioGalen manufactures Cefpodoxime Proxetil as a paediatric dry syrup (50 mg/5 ml and 100 mg/5 ml on reconstitution). Its suitability for otitis media and paediatric respiratory infections makes it an important paediatric antibiotic across the markets we serve.

Mechanism of Action

Cefpodoxime Proxetil is a prodrug ester of cefpodoxime, a third-generation cephalosporin. After oral absorption it is hydrolysed to active cefpodoxime, which inhibits bacterial cell wall synthesis by binding penicillin-binding proteins. It offers the Gram-negative reach of a third-generation cephalosporin together with useful Gram-positive activity, giving it a balanced spectrum well suited to community-acquired respiratory infections.

Indications

Community-acquired respiratory tract infections
Otitis media (middle ear infection)
Pharyngitis and tonsillitis
Skin and soft tissue infections
Uncomplicated urinary tract infections

Available Variants

Cefpodoxime Proxetil Dry Syrup 50mg/5ml
Cefpodoxime Proxetil Dry Syrup 100mg/5ml

Frequently Asked Questions

What is Cefpodoxime Proxetil used for?

Cefpodoxime Proxetil is a third-generation oral cephalosporin with balanced Gram-positive and Gram-negative activity, commonly used for community-acquired respiratory tract infections, otitis media in children, and skin infections.

How does Cefpodoxime compare to Cefixime?

Both are third-generation oral cephalosporins, but Cefpodoxime offers a more balanced spectrum with useful Gram-positive activity alongside Gram-negative coverage, making it a common respiratory and otitis media choice, while Cefixime is often used for typhoid and UTIs.

What forms of Cefpodoxime does BioGalen manufacture?

BioGalen manufactures Cefpodoxime Proxetil as a paediatric dry syrup (50 mg/5 ml and 100 mg/5 ml on reconstitution), under WHO-GMP with CTD and ACTD dossiers available.

Explore More

Interested in Cefpodoxime Proxetil Dry Syrup?

Get competitive pricing for bulk orders, private labelling, and contract manufacturing.

WhatsApp Enquiry Contact Us

Browse Categories

Browse by Dosage Form